CLINICAL_TRIALS trial_result · 2021-12-20

Clinical Trial Update: Contribution of Endothelin-1 to Exercise Intolerance in Heart Failure [EARLY_Phase 1]

Early-phase study investigating the contribution of Endothelin-1 to exercise intolerance in heart failure; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: VA Office of Research and Development | Conditions: Heart Failure | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-12-20